Skip to main content

Table 3 Incremental cost of universal GA-I newborn screening per 100,000 neonates

From: Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis

 

Mean value

95% CI

Incremental cost, 20 years horizon

−30,682 €

−14,550 € to −49,401 €

Incremental cost, 70 years horizon

−36,743 €

−19,072 € to −57,365 €